Serena Williams says she lost 30 pounds using GLP-1s

Serena Williams said she lost about 30 pounds after starting a GLP-1 medication and reported improved cholesterol and a lower projected lifetime cardiovascular risk.

Serena Williams, now retired from professional tennis, shared recent health updates tied to a GLP-1 medication. She posted photos on Instagram and discussed a partnership post in which she described measurable changes to her body and lab results over the past year. Williams said the change has been about overall wellness rather than appearance and acknowledged public debate around these medications. She also expressed a desire to reduce stigma by being open about her experience. Reported details: - Williams said she has lost roughly 30 pounds since starting the GLP-1 medication. - She reported a 19% decrease in her projected lifetime risk for cardiovascular disease. - She reported a roughly 30% improvement in total cholesterol and said some health stats are better than when she was playing tennis. - Williams described the shift as feeling healthier and lighter, said it is "not a shortcut," and noted people have told her her openness influenced their decisions. - The article notes that GLP-1 medications are commonly prescribed for diabetes and are increasingly used for weight management. Summary: Serena Williams' disclosure contributes a personal example to public conversations about GLP-1 medications and health markers. The report lists specific changes she attributes to the medication, and it notes ongoing debate about their wider use. Undetermined at this time.